Financials
- Market Capitalization 40.3896 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.16
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 5468 | CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1297 USD | +9.08% | -0.15% | +12.98% | +347.24% | 0 USD | ||
| 6285 | ADAP Adaptimmune Therapeutics plc - American Depositary Shares | 0.05 USD | 0.00% | 0.00% | -61.54% | -70.59% | 0 USD | ||
| 6647 | NAMSW NewAmsterdam Pharma Company N.V. - Warrant | 10.9500 USD | 0.00% | +2.34% | -4.70% | -59.67% | 2.41 B USD | ||
| 6711 | DRTSW Alpha Tau Medical Ltd. - Warrant | 3.5790 USD | -4.18% | -6.80% | -3.79% | +1093.00% | 1.21 B USD |